Preclinical Efficacy of [V(4)Q(5)]dDAVP, a Second Generation Vasopressin Analog, on Metastatic Spread and Tumor-Associated Angiogenesis in Colorectal Cancer

PURPOSE: Control of metastatic spread of colorectal cancer (CRC) remains as a major therapeutic challenge. [V4 Q5 ]dDAVP is a vasopressin peptide analog with previously reported anticancer activity against carcinoma tumors. By acting as a selective agonist of arginine vasopressin type 2 membrane rec...

Descripción completa

Detalles Bibliográficos
Autores principales: Garona, Juan, Sobol, Natasha T., Pifano, Marina, Segatori, Valeria I., Gomez, Daniel E., Ripoll, Giselle V., Alonso, Daniel F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Cancer Association 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6473275/
https://www.ncbi.nlm.nih.gov/pubmed/29879760
http://dx.doi.org/10.4143/crt.2018.040

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6473275/
https://www.ncbi.nlm.nih.gov/pubmed/29879760
http://dx.doi.org/10.4143/crt.2018.040

Ejemplares similares